市場調査レポート
商品コード
1498539

家禽用ワクチンの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート:タイプ別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別、地域別

Poultry Vaccines Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Technology, Dosage Form, Disease, Route of Administration, End User, and Geography


出版日
ページ情報
英文 233 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
家禽用ワクチンの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート:タイプ別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別、地域別
出版日: 2024年05月17日
発行: The Insight Partners
ページ情報: 英文 233 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

家禽用ワクチンの市場規模は、2023年の21億米ドルから2031年には41億米ドルに成長すると予測され、2021~2031年のCAGRは8.6%を記録すると予測されます。家禽疾病の新興国市場での流行が主な要因であり、静脈ワクチンや混合ワクチンの発展が家禽用ワクチン市場開拓を後押ししています。しかし、製品回収が家禽用ワクチン市場の成長を妨げています。さらに、ベクトドワクチンや混合ワクチンの進歩は、2021~2031年の間、家禽用ワクチン市場の主要動向であり続ける可能性が高いです。

促進要因

家禽疾病の流行増加が市場成長を牽引

家禽生産は、卵や肉を通じてさまざまな種類の動物性タンパク質を生産します。家禽生産の増加に伴い、特に発展途上国では、莫大な経済的損失をもたらす可能性のある「家禽病」のようないくつかの人獣共通感染症にかかりやすくなる可能性が高いです。例えば、鶏は細菌、ウイルス、寄生虫、真菌の感染症にかかりやすいです。これらのウイルス感染症は、ニューカッスル病、鳥インフルエンザ、伝染性滑液包病、その他様々な家禽の病気を引き起こす可能性があります。

家禽の病気はヒナの死亡の主な原因であり、家畜の減少にもつながります。人獣共通感染症を蔓延させ、哺乳類に深刻な健康リスクをもたらすため、農家は世界中で莫大な経済的損失に直面しています。例えば、家禽コクシジウム症は世界中で最も一般的な病気のひとつであり、死亡率や体重の減少、予防・治療管理に関する余分な出費に伴う莫大な損失につながります。DSM社のウェブサイトによると、世界の農家は鶏や鳥類のコクシジウム症により、年間30億米ドルの経済的損失に直面しています。ニューカッスル病もまた、家禽製品を輸出する発展途上国の農家に莫大な生産損失をもたらす、経済的に高価な病気と考えられています。2021年10月に発表されたInternational Journal of Current Microbiology and Applied Sciences(IJCMAS)の報告書によると、25の商業ブロイラー農場すべてにおいて、ニューカッスル病による死亡率と生鳥の総支出はそれぞれ17,864インドルピー(214.0米国ドル)から2,66,080インドルピー(3,188.89米国ドル)、2,78,393インドルピー(3,336.46米国ドル)から17,86,745インドルピー(21,413.6米国ドル)でした。また、個々の農場の生きた鳥の販売収入は、感染により1,60,255インドルピー(1,920.61米国ドル)から12,46,314インドルピー(14,936.7米国ドル)となった。

したがって、莫大な経済的損失をもたらす家禽疾病の蔓延の増加が家禽予防接種の需要を押し上げ、市場を牽引しています。

レポート区分と調査範囲:

家禽用ワクチン市場は、タイプ、技術、投与形態、疾病、投与経路、エンドユーザーに区分されます。タイプ別では、家禽用ワクチン市場はブロイラーとレイヤーに分けられます。2023年にはブロイラーセグメントがより大きな市場シェアを占めています。

技術別では、市場は弱毒生ワクチン、不活化ワクチン、組み換えワクチンに区分されます。2023年には弱毒化生ワクチンが最大の市場シェアを占めています。

投与形態では、市場は液体ワクチン、凍結乾燥ワクチン、粉塵/粉末ワクチンに分類されます。2023年には液体ワクチン分野が市場を独占しました。

疾病別では、市場は鳥インフルエンザ、鳥サルモネラ症、マレック病、伝染性気管支炎、伝染性滑液包炎(IBD)、ニューカッスル病、その他に区分されます。2023年には鳥インフルエンザ分野が市場を独占しました。

投与経路では、市場は飲料水(D/W)、筋肉内(I/M)、皮下(I/S)、その他に分類されます。2023年は飲料水(D/W)セグメントが市場を独占しました。

エンドユーザー別では、市場は養鶏場、動物病院、家禽用ワクチン接種センター&クリニックに区分されます。2023年は養鶏場セグメントが市場を独占しました。

タイプ別洞察

タイプ別では、家禽用ワクチン市場はブロイラーとレイヤーに二分されます。ブロイラー部門は、2023年に家禽用ワクチン市場で最大の市場シェアを占めました。ブロイラーは、平均体重1.5~2.0kg、柔軟な胸骨軟骨、しなやかで柔らかい肉を持つ生後6~8週間の若鶏です。食肉生産用に飼育されます。商業用ブロイラーの大半は、4~7週齢でと畜重量に達します。ブロイラー種は、早期の急速な成長を目的とした激しい品種改良により、骨格の奇形、皮膚病、眼病、うっ血性心疾患に非常にかかりやすいです。群れの健康を確保するため、換気、住居、飼養密度、社内業務が定期的に検査されます。雄は雌よりも成長が早いため、雌のブロイラーよりも高い床面積と栄養素を必要とします。そのため、多くの国では雄と雌のブロイラーヒナを別々に飼育しています。

ワクチン接種は、特に養鶏におけるブロイラーの疾病およびウイルス性疾病予防に不可欠な手段のひとつです。ワクチンには、弱毒化した病原体や、軽度の感染を引き起こす低濃度の病原体、あるいは微生物の抗原性成分が含まれており、ブロイラーに特定の疾病に対する免疫をつけることができます。マレック病のワクチンは、孵化場でブロイラーの1日齢時に皮下投与されます。そのため、ブロイラー市場は予測期間中に成長を加速させる。

地域分析:

家禽用ワクチン市場調査範囲は主に5地域に区分される:北米、アジア太平洋、欧州、中東&アフリカ、中南米です。主な市場動向、主要企業、規制、最近の市場開拓を網羅した世界および地域市場分析。

アジア太平洋地域は家禽用ワクチン市場を独占しており、今後数年間で最も高いCAGRで成長すると予測されています。アジア太平洋地域では、2023年に中国が家禽用ワクチン市場で最大のシェアを占めています。中国は急速な経済成長と都市化を目の当たりにしています。中国はこの地域で主要なヘルスケアシステムの1つです。同国における市場の成長は、家禽肉に対する需要の増加、動物由来食品の消費の増加、家畜人口の増加、動物の健康に対する意識の高まり、中国における家禽疾病の発生頻度の上昇に起因しています。そのため、中国国民の間でワクチン接種を促進するための政府の積極的な取り組みが、家禽用ワクチン市場の成長に影響を与える主要因となっています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

第4章 家禽用ワクチン市場情勢

  • PEST分析

第5章 家禽用ワクチン市場- 主要市場力学

  • 家禽用ワクチン市場:主要市場力学
  • 市場促進要因
    • 家禽疾病の流行増加
    • 家禽産業の成長
  • 市場抑制要因
    • ワクチン接種の失敗と不適切な取り扱い
  • 市場機会
    • 大量ワクチン接種への政府の支援と革新的なスキーム
  • 今後の動向
    • ベクターワクチンおよび混合ワクチンの進歩
  • 促進要因と抑制要因の影響

第6章 家禽用ワクチン市場分析

  • 家禽用ワクチンの市場収益、2023-2031年

第7章 家禽用ワクチンの市場分析:タイプ別

  • ブロイラー
  • レイヤー

第8章 家禽用ワクチンの市場分析:技術別

  • 生ワクチン
  • 不活化ワクチン
  • 組み換えワクチン

第9章 家禽用ワクチンの市場分析:投与形態別

  • 液体ワクチン
  • フリーズドライワクチン
  • 粉末ワクチン

第10章 家禽用ワクチンの市場分析:疾患別

  • 鳥インフルエンザ
  • サルモネラ症
  • マレック病
  • 感染性気管支炎(IB)
  • 感染性滑液包炎(IBD)
  • ニューカッスル病
  • その他

第11章 家禽用ワクチンの市場分析:投与経路別

  • 飲料水(D/W)
  • 筋肉内(I/M)
  • 皮下(S/C)
  • その他

第12章 家禽用ワクチンの市場分析-エンドユーザー別

  • 養鶏場
  • 動物病院
  • 家禽用ワクチン接種センターおよび診療所

第13章 家禽用ワクチン市場:地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • APACのその他諸国
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第14章 業界情勢

  • 世界の家禽用ワクチン市場における成長戦略
  • 有機的開発
  • 無機的展開

第15章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • BIOVAC
  • Phibro Animal Health Corp
  • Hester Biosciences Ltd
  • Venky's(India)Ltd
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Nisseiken Co Ltd
  • Vaccinova AB

第16章 付録

図表

List Of Tables

  • Table 1. Poultry Vaccines Market Segmentation
  • Table 2. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 3. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 5. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 6. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 7. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 8. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 10. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 11. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 12. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 13. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 16. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 17. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 18. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 19. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 22. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 23. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 24. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 25. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 26. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 27. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 28. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 29. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 30. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 31. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 32. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 33. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 34. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 35. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 36. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 37. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 38. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 39. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 40. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 41. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 42. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 43. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 44. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 45. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 46. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 47. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 48. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 49. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 50. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 51. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 52. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 53. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 54. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 55. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 56. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 57. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 58. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 59. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 60. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 61. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 62. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 63. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 64. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 65. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 66. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 67. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 68. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 69. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 70. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 71. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 72. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 73. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 74. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 75. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 76. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 77. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 78. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 79. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 80. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 81. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 82. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 83. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 84. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 85. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 86. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 87. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 88. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 89. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 90. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 91. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 92. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 93. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 94. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 95. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 96. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 97. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 98. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 99. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 100. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 101. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 102. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 103. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 104. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 105. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 106. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 107. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 108. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 109. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 110. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 111. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 112. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 113. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 114. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 115. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 116. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 117. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 118. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 119. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 120. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 121. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 122. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 123. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 124. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 125. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 126. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 127. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 128. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 129. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 130. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 131. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 132. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 133. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 134. Organic Developments Done by Companies
  • Table 135. Inorganic Developments Done by Companies
  • Table 136. Glossary of Terms, Vaccine Adjuvants Market

List Of Figures

  • Figure 1. Poultry Vaccines Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2023-2031
  • Figure 5. Poultry Vaccine Market, By Geography Forecast Analysis, 2023 & 2031
  • Figure 6. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
  • Figure 7. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
  • Figure 10. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
  • Figure 14. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
  • Figure 18. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Mareks Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Poultry Vaccines Market Share (%) - by Route Of Administration, 2023 and 2031
  • Figure 26. Drinking water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
  • Figure 31. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Poultry Vaccination Centers and Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. North America: Poultry Vaccines Market by Key Countries - Revenue (2023) US$ Million
  • Figure 35. North America: Poultry Vaccines Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 37. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 38. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 39. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 40. Europe: Poultry Vaccine Market - Revenue by Key Countries Revenue 2023 (US$ Million)
  • Figure 41. Europe: Poultry Vaccine Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 43. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 44. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 45. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 46. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 47. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 48. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 49. Asia Pacific: Poultry Vaccines Market - Revenue by Key Countries 2023 (US$ Million)
  • Figure 50. Asia Pacific: Poultry Vaccine Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 52. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 53. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 54. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 55. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 56. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 57. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 58. Middle East and Africa: Poultry Vaccines Market by Key Countries - Revenue 2023 (US$ Million)
  • Figure 59. Middle East and Africa: Poultry Vaccine Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 60. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 61. South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 62. Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 63. United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 64. Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 65. South and Central America: Poultry Vaccines Market by Key Countries - Revenue 2023 (US$ Million)
  • Figure 66. South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 68. Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 69. Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 70. Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 71. Growth Strategies in the Global Poultry Vaccines Market
目次
Product Code: TIPRE00004772

The poultry vaccines market size is projected to grow from US$ 2.1 billion in 2023 to US$ 4.1 billion by 2031; the market is estimated to record a CAGR of 8.6% during 2021-2031. The rising prevalence of poultry diseases are the key factors and advancements in vectored and combination vaccines propelling the poultry vaccines market development. However, product recall hamper the poultry vaccines market growth. Furthermore, the advancements in vectored and combination vaccines are likely to remain key poultry vaccines market trends during 2021-2031.

Growth Drivers:

Rising Prevalence of Poultry Diseases Drives Market Growth

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as "Fowl disease" that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle disease, avian influenza, infectious bursal disease, and other diseases to wide range of poultry animals.

The table below provides disease outbreaks of avian influenza among mammals across several countries in 2022.

Cases of Avian Influenza in Mammals

Country Poultry Diseases Disease Outbreak (2022)

Argentina H5 18

Chile 34

Norway 2

Uruguay 3

Peru 12

Brazil H5N1 5

Canada 40

China 1

Estonia 1

Finland 76

France 2

Ireland 2

Italy 3

Japan 4

Russia 1

Canada H5N5 2

Denmark H5N8 1

Source: World Organization for Animal Health 2023

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

Report Segmentation and Scope:

The poultry vaccines market is segmented into type, technology, dosage form, disease, route of administration, and end user. Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.

By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share of the market in 2023.

In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.

In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.

In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.

In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.

Type-Based Insights

By type, the poultry vaccines market is bifurcated into broiler and layer. The broiler segment held the largest market share of the poultry vaccines market in 2023. Broilers are young chickens of six to eight weeks of age with 1.5-2.0 kg average body weight, flexible breastbone cartilage, and pliable and soft meat. They are bred and raised for meat production. The majority of commercial broilers achieve slaughter weight between four and seven weeks of age. Due to intense breeding selection for rapid early growth, broiler breeds are highly vulnerable to skeletal deformity, skin & eye diseases, and congestive heart disorders. To ensure the well-being of the flock, ventilation, housing, stocking density, and in-house operations are examined on a regular basis. As the males grow faster than females, they need higher floor space and nutrients than female broilers. Hence, male and female broiler chicks are reared separately in many countries.

Vaccination programs are one of the essential tools for disease and viral disease prevention, especially for broilers in poultry farming. Vaccines contain the attenuated pathogen or at low concentrations that cause a mild infection or antigenic components of the microorganism, which will make the broiler immune from particular diseases. Vaccines for Marek's disease are given at the hatchery at day one age of broiler by subcutaneous route of administration. Therefore, broiler segment bolster the poultry vaccines market growth during the forecast period.

Regional Analysis:

The geographic scope of the poultry vaccines market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.

Asia Pacific has dominated the poultry vaccines market and is anticipated to grow with the highest CAGR in the coming years. In Asia Pacific, China accounted for the largest share of the poultry vaccines market in 2023. China is witnessing rapid economic growth and urbanization. China has one of the major healthcare systems in the region. The market growth in the country can be accredited to the growing demand for poultry meat, the increasing consumption of animal-derived food products, the growing livestock population, increasing awareness about animal health, and the rising frequency of poultry disease outbreaks in China. Therefore, favorable government initiatives to promote vaccination among the population of China are the key factor influencing the poultry vaccines market growth.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. Poultry Vaccines Market Landscape

  • 4.1 PEST Analysis

5. Poultry Vaccines Market - Key Market Dynamics

  • 5.1 Poultry Vaccines Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Poultry Diseases
    • 5.2.2 Growing Poultry Industry
  • 5.3 Market Restraints
    • 5.3.1 Vaccination Failure and Improper Handling
  • 5.4 Market Opportunities
    • 5.4.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 5.5 Future Trends
    • 5.5.1 Advancements in Vectored and Combination Vaccines
  • 5.6 Impact of Drivers and Restraints:

6. Poultry Vaccines Market Analysis

  • 6.1 Poultry Vaccines Market Revenue (US$ Million), 2023-2031

7. Poultry Vaccines Market Analysis - by Type

  • 7.1 Overview
  • 7.2 Broiler
    • 7.2.1 Overview
    • 7.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Layer
    • 7.3.1 Overview
    • 7.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Poultry Vaccines Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Live Attenuated Vaccines
    • 8.2.1 Overview
    • 8.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Inactivated Vaccines
    • 8.3.1 Overview
    • 8.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Recombinant Vaccines
    • 8.4.1 Overview
    • 8.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Poultry Vaccines Market Analysis - by Dosage Form

  • 9.1 Overview
  • 9.2 Liquid Vaccines
    • 9.2.1 Overview
    • 9.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Freeze-Dried Vaccines
    • 9.3.1 Overview
    • 9.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Dust/Powdered Vaccines
    • 9.4.1 Overview
    • 9.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Poultry Vaccines Market Analysis - by Disease

  • 10.1 Overview
  • 10.2 Avian Influenza
    • 10.2.1 Overview
    • 10.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Salmonellosis
    • 10.3.1 Overview
    • 10.3.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Mareks Disease
    • 10.4.1 Overview
    • 10.4.2 Mareks Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Infectious Bronchitis (IB)
    • 10.5.1 Overview
    • 10.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Infectious Bursal Disease (IBD)
    • 10.6.1 Overview
    • 10.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.7 Newcastle Disease
    • 10.7.1 Overview
    • 10.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.8 Others
    • 10.8.1 Overview
    • 10.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Poultry Vaccines Market Analysis - by Route Of Administration

  • 11.1 Overview
  • 11.2 Drinking Water (D/W)
    • 11.2.1 Overview
    • 11.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Intramuscular (I/M)
    • 11.3.1 Overview
    • 11.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Subcutaneous (S/C)
    • 11.4.1 Overview
    • 11.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Poultry Vaccines Market Analysis - by End User

  • 12.1 Overview
  • 12.2 Poultry Farms
    • 12.2.1 Overview
    • 12.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.3 Veterinary Hospitals
    • 12.3.1 Overview
    • 12.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.4 Poultry Vaccination Centers and Clinics
    • 12.4.1 Overview
    • 12.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

13. Poultry Vaccines Market - Geographical Analysis

  • 13.1 North America
    • 13.1.1 North America Poultry Vaccines Market Overview
    • 13.1.2 North America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.1.3 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 13.1.3.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.1.3.1.1 Overview
        • 13.1.3.1.2 United States: Poultry Vaccines Market Breakdown by Type
        • 13.1.3.1.3 United States: Poultry Vaccines Market Breakdown by Technology
        • 13.1.3.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.1.3.1.5 United States: Poultry Vaccines Market Breakdown by Disease
        • 13.1.3.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.1.3.1.7 United States: Poultry Vaccines Market Breakdown by End User
      • 13.1.3.2 Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.1.3.2.1 Overview
        • 13.1.3.2.2 Canada: Poultry Vaccines Market Breakdown by Type
        • 13.1.3.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
        • 13.1.3.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.1.3.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
        • 13.1.3.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.1.3.2.7 Canada: Poultry Vaccines Market Breakdown by End User
      • 13.1.3.3 Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.1.3.3.1 Overview
        • 13.1.3.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
        • 13.1.3.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
        • 13.1.3.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.1.3.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
        • 13.1.3.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.1.3.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
  • 13.2 Europe
    • 13.2.1 Europe Poultry Vaccine Market Overview
    • 13.2.2 Europe: Poultry Vaccine Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.2.3 Poultry Vaccines Market Breakdown by Countries
    • 13.2.4 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 13.2.4.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.4.1.1 Overview
        • 13.2.4.1.2 Germany: Poultry Vaccines Market Breakdown by Type
        • 13.2.4.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
        • 13.2.4.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.2.4.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
        • 13.2.4.1.6 Germany: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.2.4.1.7 Germany: Poultry Vaccines Market Breakdown by End User
      • 13.2.4.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.4.2.1 Overview
        • 13.2.4.2.2 Spain: Poultry Vaccines Market Breakdown by Type
        • 13.2.4.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
        • 13.2.4.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.2.4.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
        • 13.2.4.2.6 Spain: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.2.4.2.7 Spain: Poultry Vaccines Market Breakdown by End User
      • 13.2.4.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.4.3.1 Overview
        • 13.2.4.3.2 France: Poultry Vaccines Market Breakdown by Type
        • 13.2.4.3.3 France: Poultry Vaccines Market Breakdown by Technology
        • 13.2.4.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.2.4.3.5 France: Poultry Vaccines Market Breakdown by Disease
        • 13.2.4.3.6 France: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.2.4.3.7 France: Poultry Vaccines Market Breakdown by End User
      • 13.2.4.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.4.4.1 Overview
        • 13.2.4.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
        • 13.2.4.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
        • 13.2.4.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.2.4.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
        • 13.2.4.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.2.4.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
      • 13.2.4.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.4.5.1 Overview
        • 13.2.4.5.2 Italy: Poultry Vaccines Market Breakdown by Type
        • 13.2.4.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
        • 13.2.4.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.2.4.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
        • 13.2.4.5.6 Italy: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.2.4.5.7 Italy: Poultry Vaccines Market Breakdown by End User
      • 13.2.4.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.4.6.1 Overview
        • 13.2.4.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
        • 13.2.4.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
        • 13.2.4.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.2.4.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
        • 13.2.4.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.2.4.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User
  • 13.3 Asia Pacific
    • 13.3.1 Asia Pacific Poultry Vaccines Market Overview
    • 13.3.2 Asia Pacific: Poultry Vaccines Market
    • 13.3.3 Poultry Vaccines Market Breakdown by Countries
      • 13.3.3.1 China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.3.1.1 Overview
        • 13.3.3.1.2 China: Poultry Vaccines Market Breakdown by Type
        • 13.3.3.1.3 China: Poultry Vaccines Market Breakdown by Technology
        • 13.3.3.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.3.3.1.5 China: Poultry Vaccines Market Breakdown by Disease
        • 13.3.3.1.6 China: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.3.3.1.7 China: Poultry Vaccines Market Breakdown by End User
      • 13.3.3.2 India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.3.2.1 Overview
        • 13.3.3.2.2 India: Poultry Vaccines Market Breakdown by Type
        • 13.3.3.2.3 India: Poultry Vaccines Market Breakdown by Technology
        • 13.3.3.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.3.3.2.5 India: Poultry Vaccines Market Breakdown by Disease
        • 13.3.3.2.6 India: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.3.3.2.7 India: Poultry Vaccines Market Breakdown by End User
      • 13.3.3.3 Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.3.3.1 Overview
        • 13.3.3.3.2 Japan: Poultry Vaccines Market Breakdown by Type
        • 13.3.3.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
        • 13.3.3.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.3.3.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
        • 13.3.3.3.6 Japan: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.3.3.3.7 Japan: Poultry Vaccines Market Breakdown by End User
      • 13.3.3.4 Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.3.4.1 Overview
        • 13.3.3.4.2 Australia: Poultry Vaccines Market Breakdown by Type
        • 13.3.3.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
        • 13.3.3.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.3.3.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
        • 13.3.3.4.6 Australia: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.3.3.4.7 Australia: Poultry Vaccines Market Breakdown by End User
      • 13.3.3.5 South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.3.5.1 Overview
        • 13.3.3.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
        • 13.3.3.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
        • 13.3.3.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.3.3.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
        • 13.3.3.5.6 South Korea: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.3.3.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
      • 13.3.3.6 Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.3.6.1 Overview
        • 13.3.3.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
        • 13.3.3.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
        • 13.3.3.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.3.3.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
        • 13.3.3.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.3.3.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User
  • 13.4 Middle East and Africa
    • 13.4.1 Middle East and Africa Poultry Vaccines Market Overview
    • 13.4.2 Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.4.3 Poultry Vaccines Market Breakdown by Countries
    • 13.4.4 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 13.4.4.1 South Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.4.1.1 Overview
        • 13.4.4.1.2 The table below represents the H5N8 Avian Influenza (HPAI) outbreak from June 2017 to November 2020:
        • 13.4.4.1.3 South Africa: Poultry Vaccines Market Breakdown by Type
        • 13.4.4.1.4 South Africa: Poultry Vaccines Market Breakdown by Technology
        • 13.4.4.1.5 South Africa: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.4.4.1.6 South Africa: Poultry Vaccines Market Breakdown by Disease
        • 13.4.4.1.7 South Africa: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.4.4.1.8 South Africa: Poultry Vaccines Market Breakdown by End User
      • 13.4.4.2 Saudi Arabia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.4.2.1 Overview
        • 13.4.4.2.2 Saudi Arabia: Poultry Vaccines Market Breakdown by Type
        • 13.4.4.2.3 Saudi Arabia: Poultry Vaccines Market Breakdown by Technology
        • 13.4.4.2.4 Saudi Arabia: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.4.4.2.5 Saudi Arabia: Poultry Vaccines Market Breakdown by Disease
        • 13.4.4.2.6 Saudi Arabia: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.4.4.2.7 Saudi Arabia: Poultry Vaccines Market Breakdown by End User
      • 13.4.4.3 United Arab Emirates: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.4.3.1 Overview
        • 13.4.4.3.2 United Arab Emirates: Poultry Vaccines Market Breakdown by Type
        • 13.4.4.3.3 United Arab Emirates: Poultry Vaccines Market Breakdown by Technology
        • 13.4.4.3.4 United Arab Emirates: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.4.4.3.5 United Arab Emirates: Poultry Vaccines Market Breakdown by Disease
        • 13.4.4.3.6 United Arab Emirates: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.4.4.3.7 United Arab Emirates: Poultry Vaccines Market Breakdown by End User
      • 13.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.4.4.1 Overview
        • 13.4.4.4.2 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Type
        • 13.4.4.4.3 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Technology
        • 13.4.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.4.4.4.5 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Disease
        • 13.4.4.4.6 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.4.4.4.7 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by End User
  • 13.5 South and Central America
    • 13.5.1 South and Central America Poultry Vaccines Market Overview
    • 13.5.2 South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.5.3 Poultry Vaccines Market Breakdown by Countries
    • 13.5.4 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 13.5.4.1 Brazil: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.4.1.1 Overview
        • 13.5.4.1.2 Brazil: Poultry Vaccines Market Breakdown by Type
        • 13.5.4.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology
        • 13.5.4.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.5.4.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease
        • 13.5.4.1.6 Brazil: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.5.4.1.7 Brazil: Poultry Vaccines Market Breakdown by End User
      • 13.5.4.2 Argentina: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.4.2.1 Overview
        • 13.5.4.2.2 Argentina: Poultry Vaccines Market Breakdown by Type
        • 13.5.4.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology
        • 13.5.4.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.5.4.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease
        • 13.5.4.2.6 Argentina: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.5.4.2.7 Argentina: Poultry Vaccines Market Breakdown by End User
      • 13.5.4.3 Rest of South and Central America: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.4.3.1 Overview
        • 13.5.4.3.2 Rest of South and Central America: Poultry Vaccines Market Breakdown by Type
        • 13.5.4.3.3 Rest of South and Central America: Poultry Vaccines Market Breakdown by Technology
        • 13.5.4.3.4 Rest of South and Central America: Poultry Vaccines Market Breakdown by Dosage Form
        • 13.5.4.3.5 Rest of South and Central America: Poultry Vaccines Market Breakdown by Disease
        • 13.5.4.3.6 Rest of South and Central America: Poultry Vaccines Market Breakdown by Route Of Administration
        • 13.5.4.3.7 Rest of South and Central America: Poultry Vaccines Market Breakdown by End User

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Global Poultry Vaccines Market
  • 14.3 Organic Developments
    • 14.3.1 Overview
  • 14.1 Inorganic Developments
    • 14.1.1 Overview

15. Company Profiles

  • 15.1 Boehringer Ingelheim International GmbH
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Zoetis Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 BIOVAC
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Phibro Animal Health Corp
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Hester Biosciences Ltd
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Venky's (India) Ltd
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Dechra Pharmaceuticals PLC
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Elanco Animal Health Inc
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Merck KGaA
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Ceva
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 Nisseiken Co Ltd
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Vaccinova AB
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms